Tags

Type your tag names separated by a space and hit enter

Baricitinib as potential treatment for 2019-nCoV acute respiratory disease.
Lancet. 2020 02 15; 395(10223):e30-e31.Lct

Authors+Show Affiliations

BenevolentAI, London, UK.BenevolentAI, London, UK.BenevolentAI, London, UK.BenevolentAI, London, UK.BenevolentAI, London, UK.BenevolentAI, London, UK.BenevolentAI, London, UK.BenevolentAI, London, UK.Department of Surgery and Cancer, Imperial College London, London SW7 2AZ, UK. Electronic address: j.stebbing@imperial.ac.uk.

Pub Type(s)

Letter

Language

eng

PubMed ID

32032529

Citation

Richardson, Peter, et al. "Baricitinib as Potential Treatment for 2019-nCoV Acute Respiratory Disease." Lancet (London, England), vol. 395, no. 10223, 2020, pp. e30-e31.
Richardson P, Griffin I, Tucker C, et al. Baricitinib as potential treatment for 2019-nCoV acute respiratory disease. Lancet. 2020;395(10223):e30-e31.
Richardson, P., Griffin, I., Tucker, C., Smith, D., Oechsle, O., Phelan, A., Rawling, M., Savory, E., & Stebbing, J. (2020). Baricitinib as potential treatment for 2019-nCoV acute respiratory disease. Lancet (London, England), 395(10223), e30-e31. https://doi.org/10.1016/S0140-6736(20)30304-4
Richardson P, et al. Baricitinib as Potential Treatment for 2019-nCoV Acute Respiratory Disease. Lancet. 2020 02 15;395(10223):e30-e31. PubMed PMID: 32032529.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Baricitinib as potential treatment for 2019-nCoV acute respiratory disease. AU - Richardson,Peter, AU - Griffin,Ivan, AU - Tucker,Catherine, AU - Smith,Dan, AU - Oechsle,Olly, AU - Phelan,Anne, AU - Rawling,Michael, AU - Savory,Edward, AU - Stebbing,Justin, Y1 - 2020/02/04/ PY - 2020/02/03/received PY - 2020/02/03/accepted PY - 2020/2/8/pubmed PY - 2020/3/17/medline PY - 2020/2/8/entrez SP - e30 EP - e31 JF - Lancet (London, England) JO - Lancet VL - 395 IS - 10223 SN - 1474-547X UR - https://www.unboundmedicine.com/medline/citation/32032529/Baricitinib_as_potential_treatment_for_2019_nCoV_acute_respiratory_disease_ L2 - https://linkinghub.elsevier.com/retrieve/pii/S0140-6736(20)30304-4 DB - PRIME DP - Unbound Medicine ER -